Replies to post #797 on Merck and Co Inc (MRK)

[DewDiligence]

Re: MRK’s Islatravir safety

From 11/23/21 post (#msg-166887916):

The trial that led to MRK’s dropping MK-8507 was testing the combination of MK-8507 and Islatravir. Although MRK says Islatravir did not play a role in the observed safety problem, it sounds like GILD is not fully convinced.

Neither is the FDA, evidently.

[DewDiligence]

FDA allows some Islatravir trials to_resume_at_a lower dose:

https://finance.yahoo.com/news/merck-initiate-phase-3-clinical-104500524.html